Human monoclonal antibodies targeting the s2 subunit of the sars-cov-2 spike protein
AssigneesBoard of Regents, The University of Texas System, The University of North Carolina at Chapel Hill
InventorsGregory C. IPPOLITO, Jason J. LAVINDER, George GEORGIOU, William N. VOSS, Ralph BARIC
Life of this patent
Estimating the term…
Abstract
Provided herein are antibodies and antibody fragments that bind to the S2 subunit of the SARS-CoV-2 spike protein. Methods of treating or preventing SARS-CoV-2 infections are provided, comprising administering to a patient in need thereof an effective amount of a SARS-CoV-2 spike protein S2 subunit-targeting antibody.
Claims43
A monoclonal antibody or antibody fragment, wherein the antibody or antibody fragment comprises clone-paired heavy and light chain CDR sequences derived from the clone-paired heavy chain and light chain variable sequences of Table 2.
Dependencies are inferred from the claim text.